PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anthracycline based chemotherapy|DRUG: taxane-based chemotherapy
Sponsor: Jenny C. Chang, MD
Collaborators: GE Healthcare|The Methodist Hospital Research Institute